Description: InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Home Page: www.inspiremd.com
4 Menorat Hamaor Street
Tel Aviv,
6744832
Israel
Phone:
972 3 6917691
Officers
| Name | Title |
|---|---|
| Mr. Marvin L. Slosman | President, CEO & Director |
| Mr. Craig Shore | CFO, Chief Administrative Officer, Secretary & Treasurer |
| Mr. Shane Thomas Gleason | Chief Commercial Officer |
| Mr. Andrea Tommasoli | Chief Operating Officer |
| Mr. Amir Kohen | Senior Vice President of Finance & HR |
| Dr. Patrick A. Verta DVM, M.D., MS Stat | Executive Vice President of Clinical & Medical Affairs |
| Mr. Pete J. Ligotti | Executive VP & GM of North America |
| Dr. Sol J. Barer Ph.D. | Special Advisor to the Board |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 11.2486 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.8963 |
| Price-to-Sales TTM: | 10.9497 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 65 |